Molecular Hydrogen Therapy
Jul 31, 2023 09:31AM ● By Nancy Bittinger
Molecular hydrogen therapy (MHT)
has been found in emerging scientific studies to protect against the shortening
of telomeres during the cell reproduction process. As telomeres shorten, cells
degrade when they divide and reproduce, causing aging in the body. A six-month
clinical trial, “Hydrogen-rich Water for Molecular and Phenotypic Biomarkers of
Aging” published at ClinicalTrials.gov has shown that not only can MHT
prevent the shortening of telomeres, but is proven to grow them.
Their conclusion is, “Owing to pleiotropic mechanisms of hydrogen action, this simple biomedical gas could be recognized as a possible anti-aging agent that tackles several hallmarks of aging, including loss of function and telomere length shortening.”
Further studies indicate promising results for MHT as an antioxidant, neutralizing harmful free radicals, combating oxidative stress, improving energy levels and cognitive function, supporting cardiovascular health, reducing inflammation, increasing athletic performance and promoting overall vitality.
Nancy Bittinger is the owner of Carlisle Bowen Works, located at 616 W. Main St., in Mechanicsburg. For more information, call 717-386-8279, email [email protected] or email CarlisleBowenWorkPA.com.
